Analysed Liminatus Pharma Inc (LIMN:NASDAQ) News Sources
Zydus Lifesciences to launch generic semaglutide injection for weight loss, diabetes after Ozempic’s patent expiry
The Financial Express
Type 2 diabetes: As Semaglutide goes off patent, drugmakers compete on differentiation, not just price
Business Today on MSN
Shilpa Medicare's biopharma subsidiary inks licensing agreement with SteinCares for Latin America
Business Standard
What is the current price of Liminatus Pharma Inc (LIMN:NASDAQ)?
The current price of Liminatus Pharma Inc (LIMN:NASDAQ) is $0.2299.
Liminatus Pharma Inc (LIMN:NASDAQ) absolute price change since previous trading day?
The absolute price change of Liminatus Pharma Inc (LIMN:NASDAQ) since the previous trading day is $-0.01.
Liminatus Pharma Inc (LIMN:NASDAQ) percentage price change since previous trading day?
The percentage price change of Liminatus Pharma Inc (LIMN:NASDAQ) since the previous trading day is -4.21%.
What is This Week's average sentiment score for Liminatus Pharma Inc (LIMN:NASDAQ)?
This Week's average sentiment score for Liminatus Pharma Inc (LIMN:NASDAQ) is 59 out of 100.
What is This Week's average sentiment for Liminatus Pharma Inc (LIMN:NASDAQ)?
This Week's sentiment for Liminatus Pharma Inc (LIMN:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.